This proposal seeks to be a participating clinical center (PCC) in the RFA entitled """"""""Polycystic Kidney Disease: Innovate Imaging Techniques."""""""" ADPKD is the most common inherited and renal disease accounting for 4% of the ESRD population in the U.S.A. Therapies aimed at slowing or halting the progression of renal failure in human ADPKD have not been successful. Given the slow pace of ADPKD, it is important to identify individual at high risk for progression to ESRD and surrogate markers early in the course of the disease so that potentially helpful interventions can be tested. This site intends to measure the rate of progression of renal disease in ADPKD subjects with normal renal function at high risk (including Afro-American race) as compared to matched ADPKD patients at low risk for progression to ESRD. Specifically, it will be determined if disease progression should be measured by change in renal cyst and parenchyma volume measured by magnetic resonance imaging as compared to change in glomerular filtration rate in either group. It will be determined if different patterns of change in renal cyst and parenchyma volume occur in ADPKD individuals at high as opposed to low risk for progression; e.g., increased renal parenchyma may predominate in high risk individuals. Renal volume increases in ADPKD children in excess of normal renal growth, however, the characteristics of renal structural change in ADPKD children is not understood with regard to cystic and parenchymal growth and echogenicity. Relative changes over time may be important in predicting disease outcome. This study will characterize APDKD children in comparison to unaffected, unrelated children where normal renal growth is occurring using both ultrasound and magnetic resonance imaging to address these questions. This study will provide new information with regard to the radiographic characteristics of disease progression in APDKD, increase understanding of the processes involved early in renal disease progression, provide accurate measurement of makers of disease progression early in ADPKD, and provide genetic, phenotypic and radiographically well characterized patients who will benefit most from therapeutic intervention.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project--Cooperative Agreements (U01)
Project #
1U01DK056956-01
Application #
6045923
Study Section
Special Emphasis Panel (ZDK1-GRB-7 (O1))
Program Officer
Flessner, Michael Francis
Project Start
2000-02-01
Project End
2004-11-30
Budget Start
2000-02-01
Budget End
2000-11-30
Support Year
1
Fiscal Year
2000
Total Cost
$496,891
Indirect Cost
Name
Emory University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Yu, Alan S L; Shen, Chengli; Landsittel, Douglas P et al. (2018) Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease. Kidney Int 93:691-699
Cornec-Le Gall, Emilie; Olson, Rory J; Besse, Whitney et al. (2018) Monoallelic Mutations to DNAJB11 Cause Atypical Autosomal-Dominant Polycystic Kidney Disease. Am J Hum Genet 102:832-844
Wynne, Brandi M; McCarthy, Cameron G; Szasz, Theodora et al. (2018) Protein kinase C? deletion causes hypotension and decreased vascular contractility. J Hypertens 36:510-519
McKenzie, Katelyn A; El Ters, Mirelle; Torres, Vicente E et al. (2018) Relationship between caffeine intake and autosomal dominant polycystic kidney disease progression: a retrospective analysis using the CRISP cohort. BMC Nephrol 19:378
Perrone, Ronald D; Mouksassi, Mohamad-Samer; Romero, Klaus et al. (2017) Total Kidney Volume Is a Prognostic Biomarker of Renal Function Decline and Progression to End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease. Kidney Int Rep 2:442-450
Shen, Chengli; Landsittel, Douglas; Irazabal, María V et al. (2017) Performance of the CKD-EPI Equation to Estimate GFR in a Longitudinal Study of Autosomal Dominant Polycystic Kidney Disease. Am J Kidney Dis 69:482-484
Kline, Timothy L; Korfiatis, Panagiotis; Edwards, Marie E et al. (2017) Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease. Kidney Int 92:1206-1216
Torres, Vicente E; Abebe, Kaleab Z; Schrier, Robert W et al. (2017) Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease. Kidney Int 91:493-500
Perrone, Ronald D; Mouksassi, Mohamad-Samer; Romero, Klaus et al. (2017) A Drug Development Tool for Trial Enrichment in Patients With Autosomal Dominant Polycystic Kidney Disease. Kidney Int Rep 2:451-460
Kim, Youngwoo; Bae, Sonu K; Cheng, Tianming et al. (2016) Automated segmentation of liver and liver cysts from bounded abdominal MR images in patients with autosomal dominant polycystic kidney disease. Phys Med Biol 61:7864-7880

Showing the most recent 10 out of 41 publications